ArticleJournal of Cancer2024

The Efficacy and Safety of Anlotinib Plus Etoposide with Cisplatin/Carboplatin in the First-Line Treatment of Lung Cancer: A Phase II Clinical Study.

Xiao-Ming Lv et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.